BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37078949)

  • 1. Lower Interobserver Reliability for Nondimensional Intracystic Features Among Abdominal Radiologists for Characterizing Intraductal Papillary Mucinous Neoplasms Using Magnetic Resonance Imaging.
    Scherer JA; Gebhard R; Firkins SA; Shah ZK; Urbina Andersson IK; Barker SJ; Fiorillo LE; Hollander E; Shaheen N; Koay EJ; Conwell DL; Krishna SG
    Pancreas; 2022 Oct; 51(9):1225-1230. PubMed ID: 37078949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
    Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
    Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
    Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
    Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.
    Kawakami S; Fukasawa M; Shimizu T; Ichikawa S; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Hayakawa H; Nakayama Y; Yamaguchi T; Inoue T; Maekawa S; Kawaida H; Motosugi U; Onishi H; Enomoto N
    Medicine (Baltimore); 2019 Nov; 98(47):e18039. PubMed ID: 31764824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cystic neoplasms and post-inflammatory cysts: interobserver agreement and diagnostic performance of MRI with MRCP.
    Tirkes T; Patel AA; Tahir B; Kim RC; Schmidt CM; Akisik FM
    Abdom Radiol (NY); 2021 Sep; 46(9):4245-4253. PubMed ID: 34014363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
    Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
    Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
    Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.
    Castelli F; Bosetti D; Negrelli R; Di Paola V; Zantedeschi L; Ventriglia A; Manfredi R; Mucelli RP
    Radiol Med; 2013 Sep; 118(6):917-29. PubMed ID: 23801393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
    Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
    Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography.
    Girometti R; Pravisani R; Intini SG; Isola M; Cereser L; Risaliti A; Zuiani C
    World J Gastroenterol; 2016 Nov; 22(43):9562-9570. PubMed ID: 27920477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography.
    Kim SH; Lee JM; Lee ES; Baek JH; Kim JH; Han JK; Choi BI
    Radiology; 2015 Mar; 274(3):723-33. PubMed ID: 25302831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Liu X; Xu W; Liu Z; Ye J
    Curr Med Imaging Rev; 2019; 15(5):504-510. PubMed ID: 32008558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
    Manfredi R; Graziani R; Motton M; Mantovani W; Baltieri S; Tognolini A; Crippa S; Capelli P; Salvia R; Pozzi Mucelli R
    Radiology; 2009 Oct; 253(1):106-15. PubMed ID: 19703865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI findings of intraductal papillary mucinous neoplasms (IPMNs).
    Lana S; Vallara M; Bono NE; Russo G; Artioli G; Capretti G; Paladini I; Pesce A; Ruggirello M; Barbalace S; Mostardi M
    Acta Biomed; 2016 Jul; 87 Suppl 3():28-33. PubMed ID: 27467864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.